Modulation of the differentiation status of cultured prostatic smooth muscle cells by an ?1-adrenergic receptor antagonist
- 5 May 1999
- journal article
- Published by Wiley in The Prostate
- Vol. 39 (4), 226-233
- https://doi.org/10.1002/(sici)1097-0045(19990601)39:4<226::aid-pros2>3.0.co;2-8
Abstract
BACKGROUND Prostatic stromal cells are believed to be a key factor in the pathogenesis of benign prostatic hyperplasia (BPH). The effect of phenylephrine, an α1‐adrenergic receptor agonist, and doxazosin, an α1‐adrenergic receptor‐specific antagonist, on the expression of smooth muscle myosin‐heavy‐chain isotypes SM‐1 and SM‐2 was tested in an in vitro model of prostatic smooth muscle cells (SMC). METHODS Primary prostatic stromal cells, grown in SMC‐specific medium, were treated with 10 μM of phenylephrine or 1 μM of doxazosin or a combination of both. SM‐2 to SM‐1 mRNA ratios and expression of α1‐adrenergic receptor subtypes were determined by means of reverse transcriptase polymerase chain reaction (RT‐PCR) techniques. Cell growth was measured by a cell viability assay. RESULTS SM‐1 mRNA and only very low levels of SM‐2 mRNA were detected in prostatic SMC cultures grown for 4 days in a serum‐free base medium. After 6 days of treatment, SM‐2 expression increased, highest in the doxazosin‐treated cultures. In comparison to unstimulated cells, a statistically significant 10‐fold increase of the SM‐2:SM‐1 ratio was measured in doxazosin‐treated cultures. Analysis of α1‐adrenergic receptor subtype expression revealed the presence of mRNAs of subtypes 1d and 1b mRNAs. Subtype 1a was not expressed. Phenylephrine and doxazosin showed no significant effect on cell proliferation and on α1d‐adrenergic receptor expression. CONCLUSIONS SMC can differentiate from a proliferative to a contractile phenotype, which is accompanied by increased expression of isotope 2 of smooth muscle myosin heavy chain. Our results suggest that doxazosin seems to have a long‐term effect on the differentiation of prostatic stromal cells, indicating that α1‐adrenergic receptor antagonists do not act solely on SMC contractility. Prostate 39:226–233, 1999.Keywords
This publication has 23 references indexed in Scilit:
- PATTERNS OF MESSENGER RNA EXPRESSION FOR alpha 1-ADRENOCEPTOR SUBTYPES IN HUMAN CORPUS CAVERNOSUMJournal of Urology, 1998
- INDUCTION OF PROSTATE APOPTOSIS BY DOXAZOSIN IN BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 1998
- Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markersThe Prostate, 1997
- ??1-Blockers vs 5??-Reductase Inhibitors in Benign Prostatic HyperplasiaDrugs & Aging, 1995
- Identification of α1-adrenoceptor subtypes present in the human prostateLife Sciences, 1994
- Cloning, Expression and Characterization of Human α Adrenergic Receptors α1a, α1b and α1cBiochemical and Biophysical Research Communications, 1994
- Phenotypic Modulation of Smooth Muscle Cells during Progression of Human Atherosclerosis as Determined by Altered Expression of Myosin Heavy Chain IsoformsAnnals of the New York Academy of Sciences, 1994
- Phenotypic changes of human smooth muscle cells during development: Late expression of heavy caldesmon and calponinDevelopmental Biology, 1992
- Effects of doxazosin on serum lipids: A review of the clinical data and molecular basis for altered lipid metabolismAmerican Heart Journal, 1991